PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Plasmatic serine protease inhibitors in blood of operated patients with carcinoma prostate
Article published in Urologia Polska 1994/47/3.

authors

Zbigniew Ziętek, Iza Iwan-Ziętek, Maria Kotschy, Ferdynand Tyloch
Z Katedry i Zakładu Patofizjologii AM w Bydgoszczy
Kierownik: Prof. dr hab. n. med. M. Kotschy
Z Katedry i Kliniki Urologii AM w Bydgoszczy
p.o. Kierownik: Dr n. med. F. Tyloch

summary

The activity of plasmatic serine protease inhibitors of blood coagulation and fibrinolysis
were checked on the background of selected parameters of haemostasis process with the patients
suffering from the prostatic carcinoma.
Before the operation low activity of AT III, alpha 2-AP, alpha 2-MG and PC and high
activity of alpha 1-PI was observed. After the operation was noticed a far decreased activity of
AT III, alpha 2-AP, alpha 2-MG and PC. Before and after an operation the dimnished activity
of plasmatic serine protease inhibitors was the proof for their consumption in the activation of
fibrynolysis and blood coagulation process. Carcinoma prostate and the operation on morbid
prostatic gland induced the release of activators of blood coagulation and fibrynolysis

references

  1. 1.Al-Mondhiry H.: Tumor interaction with hemostasis:The rational for the use of platelet inhibitors and anticoagulants in the treatment of cancer.Am. J. Hematol., 1984, 16, 193. —
  2. 2. Ambroż W. i wsp.: Skaza fibrynolityczna po operacjach na gruczole krokowym. Pol. Przeg. Chir., 1967, 39, 1098. —
  3. 3. Andersson L.: Fibrinolysis in patients with prostatic cancer.Acta Chir. Scand., 1963, 126, 172. —
  4. 4. Blomback i wsp.: Changes in blood coagulation and fibrinolysis in patients on different treatment regimens for prostatic cancer. Predictors for
  5. cardivascular complications? Thromb. Res., 1988, 49, 111. —
  6. 5. Campos-Freire i wsp.: Blood
  7. loss during and following transurethral resection. Prostate, 1986, 8 (1), 87. — 6. Dobbs R.M. i wsp.: Cloning predispotion in carcinoma of the prostate. J. Urol., 1980, 123, 706. — 7. Doli D.C. i wsp.: Acute gastrointestinal bleeding as the presenting manifestation of prostate cancer. Cancer, 1986, 58, 1374. —
  8. 8. Esparaza R., Green D.: A study of proteins C and S in patients with prostatic disease. Thromb. Haemost., 1988, 60(1), 122. —
  9. 9. Gormsen H., Hansen J.M.:
  10. Coexistence of hypercoagulability and hyperfibrinolysis in vitro following prostatectomy for benign hypertrophy. Acta Chir. Scand., 1961, 122, 471. —
  11. 10. Kester R.C.: Plasminogen activator in the human prostate. J. Clin. Path., 1969, 442.
  12. 11.Kirchheimer J., Binder B.R.: Localization and immunological characterisation of plasmonogen activators in human prostate tissue. Haemost., 1983, 13, 358. —
  13. 12. Kuzaka B., Niewiarowska M.: Układ krzepnięcia u chorych na raka gruczołu krokowego. Pol. Tyg. Lek., 1985, 22, 631. —
  14. 13. Mertens B.F.: Fibrynolytic split products (FSP) and ethanol gelation test in preoperative evaluation of patients with prostatic disease. Mayo Clin. Proc, 1974, 49, 640.
  15. 14. Nanninga P.B. i wsp.: Low prevelance of coagulation and fibrinolytic activition in patients with primary untreated cancer. Thromb. Haemost., 1990, 64(3), 361. —
  16. 15. Oliveria P.D. i wsp.: Proteins C and S in patients with advanced prostatic cancer. Thromb. Res., 1992, 63, 195. — 16. Rapaport S.I. i wsp.: Coexistent hypercoagulability and acute hyperfibrynogenemia in a patient with prostatic carcinoma. Am. J. Med., 1959, 7, 144. —
  17. 17. Tagnon H.J. i wsp.: The significance
  18. of fibrinolysis occuring in patients with metastaic cancer of prostate. Cancer, 1953, 6, 63. —
  19. 18. Varenhost E., i wsp.: Effects of estrogens orchidectomy and cyproterone aceteate on the antithrombin III concentration in carcinoma of the prostate. Urol. Res., 1981, 9, 25. —
  20. 19. Wolfart R., Farbiszewski R.: Zaburzenia w układzie krzepnięcia krwi i fibrynolizy po operacjach na gruczole krokowym. Pol. Przeg.Chir., 1971,43,321.

correspondence

dr n. med. Zbigniew Ziętek
85-090 Bydgoszcz, ul. Powst. Wlkp. 44/28